This inventor holds 53 USPTO granted patents and 36 published patent applications, plus 6 CIPO patents and 10 EPO patents, primarily in Glucose Control Systems. Top assignees: Beta Bionics, Inc., Boston University, The General Hospital Corporation. Active years: 2010-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:




Years Active: 2010-2026
Areas of Expertise:
Title: Firas H El-Khatib: Pioneering Innovator in Ambulatory Medicament Technologies
Introduction:
In the realm of medical innovation, Firas H El-Khatib has made an indelible mark with his groundbreaking work in the development of ambulatory medicament devices. Hailing from Allston, MA, Firas has amassed an impressive portfolio of 42 patents, revolutionizing the way medical devices monitor patients and deliver therapies. This article explores Firas H El-Khatib's latest patents, career highlights, notable collaborations, and the impact of his inventions on the medical field.
Latest Patents:
Firas H El-Khatib's latest patents focus on ambulatory medicament devices and their functionalities. One notable invention is the "Ambulatory Medicament Device with Alarm" system. This technology utilizes a touchscreen display interface to monitor device status and the health condition of patients receiving therapies. It enables users to receive real-time updates and display alarm indicators associated with the device's status or the patient's well-being. Additionally, Firas has developed methods to modify control parameters through a therapy change interface, enhancing the user's ability to control the therapy delivery.
Another significant invention is the "Infusion System and Components Thereof." This system utilizes multi-medicament infusion technology to prevent cross-channeling of different medicaments. The inclusion of specially designed medicament reservoirs and collars ensures that only configurations compliant with a predetermined selection can be used. These innovations in infusion systems provide increased safety and accuracy in medication delivery.
Career Highlights:
Throughout his career, Firas H El-Khatib has worked with renowned organizations such as Beta Bionics, Inc. and Boston University. Collaborating with these institutions has allowed him to leverage cutting-edge research and technological advancements. His work has positioned him as a prominent figure in the field of ambulatory medicament devices, focusing on improving patients' lives through innovative medical solutions.
Collaborations:
Firas has collaborated closely with several notable individuals in his field. One such collaborator is Edward R Damiano, a prominent researcher and developer of the groundbreaking "bionic pancreas." Their partnership has resulted in advances in automating insulin and glucagon delivery, offering new hope for individuals living with diabetes.
Another collaborator of Firas is Michael J Rosinko, a distinguished engineer specializing in the development of medical devices. Together, they have pioneered infusion system innovations, focusing on enhancing medication administration, safety, and precision.
Conclusion:
Firas H El-Khatib's relentless pursuit of innovation in the realm of ambulatory medicament devices has significantly impacted the medical field. His latest patents, including the Ambulatory Medicament Device with Alarm and Infusion System technologies, showcase his commitment to improving patient care and safety. With a wealth of expertise gained through collaborations with prominent figures like Edward R Damiano and Michael J Rosinko, Firas continues to push the boundaries of medical innovation. Through his groundbreaking inventions, Firas H El-Khatib is undeniably shaping the future of ambulatory medicament technologies, offering hope for enhanced patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile